Brent Pfeiffenberger - 07 Mar 2024 Form 4 Insider Report for Butterfly Network, Inc. (BFLY)

Role
President and CEO, Director
Signature
/s/ Douglas Carr, Attorney-in-Fact
Issuer symbol
BFLY
Transactions as of
07 Mar 2024
Net transactions value
$0
Form type
4
Filing time
11 Mar 2024, 19:37:46 UTC
Previous filing
06 Dec 2023
Next filing
06 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BFLY Common Stock Award $0 +17,425 +1.2% $0.000000 1,470,704 07 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BFLY Stock Option (right to buy) Award $0 +104,550 $0.000000 104,550 07 Mar 2024 Common Stock 104,550 $5.32 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 25% on March 7, 2025, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.
F2 The option vests 25% on March 7, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.

Remarks:

Exhibit 24 - Power of Attorney